Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 70.907
Filtrar
1.
Am J Epidemiol ; 190(9): 1724-1726, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-34467405

RESUMEN

The annual meeting of the Society for Epidemiologic Research is a prominent showcase for epidemiologists to present their research and share their expertise with peers. There are multiple paths to being on a podium at the meeting, and that role has implications for not only the speaker but also the audience. The article by Nobles et al. (Am J Epidemiol. 2021;190(9):1710-1720) represents an innovative investigation of representation among speakers at 3 recent SER annual meetings, with a primary focus on gender. Women were significantly under-represented as symposium speakers, which is an important role at the meeting. Symposium talks are invited talks and thus recognition of stature in the field. However, women were not under-represented as speakers in the concurrent contributed sessions, which are not invited talks and undergo blinded peer review. This gender contrast between the speakers at concurrent contributed sessions and the symposia is likely due to the different submission processes for the 2 types of presentations, but it could also reflect the review processes. Although the symposia are highly informative and enjoyable components of the meetings, some modifications in the submission and evaluation processes may be beneficial.


Asunto(s)
Equidad de Género , Médicos Mujeres , Estudios Epidemiológicos , Femenino , Humanos , Sociedades Médicas
2.
Am J Epidemiol ; 190(9): 1727-1729, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-34467406

RESUMEN

In the article by Nobles et al. (Am J Epidemiol. 2021;190(9):1710-1720), characteristics of those epidemiologists selected for various chair and presentation roles at the annual meetings of the Society for Epidemiologic Research (SER) from 2015 through 2017 were examined. Characteristics that were compared included inferred gender, institutional affiliation, subject area, and h-index. Important disparities were observed between session chairs, speakers, and poster presenters. SER leadership considers diversity and equity to be priorities and is committed to positive change. New programs and processes have been used to broaden participation and improve diversity since 2018, but the SER must continue its efforts to change processes and monitor of the experiences of SER members. A diversity of perspectives within the SER membership and at its meetings will improve all aspects of our practice of epidemiology.


Asunto(s)
Epidemiólogos , Sociedades Médicas , Humanos , Liderazgo
3.
J Trauma Nurs ; 28(5): 316-322, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34491949

RESUMEN

BACKGROUND: The Pediatric Trauma Society (PTS) is a multidisciplinary organization, with scientific presentations at its annual meeting addressing trauma care from prehospital through rehabilitation. OBJECTIVE: The purpose of this study was to identify and describe the scholarly areas of focus of presentations at the annual meeting over the society's first 5 years and evaluate research dissemination. METHODS: Data were collected on abstracts presented between 2014 and 2018, including titles, authors, and abstract classification. PubMed and Google Scholar searches identified abstracts that resulted in publications. Journal impact factors were identified. RESULTS: Over 5 years, 491 of 635 (77.3%) abstracts were accepted. The number of submitted and accepted abstracts increased, but the acceptance rate was stable (range = 72.1%-81.2%, p = NS [nonsignificant]). The most frequently accepted categories included "Epidemiology," "Abdominal or Thoracic Trauma," and "Neurosurgery or Traumatic Brain Injury (TBI)," whereas "Trauma Nursing" and "Quality Improvement" were less common. Among the 2014-2016 abstracts, 55.4% of podium and 24.3% of poster presentations were published. Abstracts categorized as "Epidemiology," "Education & Injury Prevention," and "Neurosurgery or TBI" were commonly presented but uncommonly published. The median journal impact factor of publications was 2.1 and 2.0 for podium and poster presentations, respectively (ranging from 0.11 to 10.25). CONCLUSION: Most of the scholarly effort presented at the PTS remains unpublished. Published work is mainly in low-impact factor journals. Mentorship in the publication process and encouragement of multidisciplinary collaboration within the society are needed to address limitations in the number and potential impact of the scientific content of the annual meeting. This type of analysis is relevant not only to the PTS but also to any professional society seeking to improve its impact.


Asunto(s)
Sociedades Médicas , Niño , Humanos
4.
Am J Epidemiol ; 190(9): 1710-1720, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-34467404

RESUMEN

The annual meeting of the Society for Epidemiologic Research (SER) is a major forum for sharing new research and promoting the career development of participants. Because of this, evaluating representation in key presentation formats is critical. For the 3,257 presentations identified at the 2015-2017 SER annual meetings, we evaluated presenter characteristics, including gender, affiliation, subject area, and h-index, and representation in 3 highlighted presentation formats: platform talks (n = 382), invited symposium talks (n = 273), and chairing a concurrent contributed session or symposium (n = 188). Data were abstracted from SER records, abstract booklets, and programs. Gender was assessed using GenderChecker software, and h-index was determined using the Scopus application programming interface. Log-binomial models were adjusted for participant characteristics and conference year. In adjusted models, women were less likely than men to present an invited symposium talk (relative risk = 0.60, 95% confidence interval: 0.45, 0.81) compared with all participants with accepted abstracts. Researchers from US public universities, US government institutions, and international institutions were less likely to present a symposium talk or to chair a concurrent contributed session or symposium than were researchers from US private institutions. The research areas that were most represented in platform talks were epidemiologic methods, social epidemiology, and cardiovascular epidemiology. Our findings suggest differences in representation by gender, affiliation, and subject area after accounting for h-index.


Asunto(s)
Bibliometría , Congresos como Asunto/estadística & datos numéricos , Métodos Epidemiológicos , Epidemiología/estadística & datos numéricos , Sociedades Médicas/estadística & datos numéricos , Femenino , Equidad de Género , Humanos , Masculino
6.
Rinsho Ketsueki ; 62(8): 1349-1356, 2021.
Artículo en Japonés | MEDLINE | ID: mdl-34497226

RESUMEN

Conflict of interest (COI) is a conflict between related parties, such as researchers, research institutions, academic societies, and third parties (commercial companies and patients). COI sometimes twists research and clinical practice, resulting in the profit instruction of related individuals or organizations. In medical research, high ethical standards are demanded to protect human rights, life, and safety of study participants, and COI must be properly enforced to maintain study fairness and ensure transparency. In Japan, the Japanese Association of Medical Science issued COI guideline in 2017, which formed the basis of many societies in making their common COI guidelines. The Japanese Society of Hematology issued COI management guideline in 2018 and is strictly managing COI of its members, organization, and clinical guideline committee members. As industry-academia collaboration activities become more active, the concept of COI is deepening; therefore, appropriate COI disclosure should be conducted based on recent trends to promote sound research and business activities.


Asunto(s)
Conflicto de Intereses , Hematología , Revelación , Humanos , Japón , Sociedades Médicas
8.
Rofo ; 193(S 02): S65, 2021 09.
Artículo en Alemán | MEDLINE | ID: mdl-34470069
11.
Diabetes Metab J ; 45(4): 461-481, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-34352984

RESUMEN

The Committee of Clinical Practice Guidelines of the Korean Diabetes Association (KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and prediabetes and published the seventh edition in May 2021. We performed a comprehensive systematic review of recent clinical trials and evidence that could be applicable in real-world practice and suitable for the Korean population. The guideline is provided for all healthcare providers including physicians, diabetes experts, and certified diabetes educators across the country who manage patients with diabetes or the individuals at the risk of developing diabetes mellitus. The recommendations for screening diabetes and glucose-lowering agents have been revised and updated. New sections for continuous glucose monitoring, insulin pump use, and non-alcoholic fatty liver disease in patients with diabetes mellitus have been added. The KDA recommends active vaccination for coronavirus disease 2019 in patients with diabetes during the pandemic. An abridgement that contains practical information for patient education and systematic management in the clinic was published separately.


Asunto(s)
Diabetes Mellitus , COVID-19/epidemiología , COVID-19/prevención & control , Vacunas contra la COVID-19/administración & dosificación , Diabetes Mellitus/terapia , Humanos , Ensayos Clínicos Controlados no Aleatorios como Asunto , Pandemias , Ensayos Clínicos Controlados Aleatorios como Asunto , República de Corea/epidemiología , Sociedades Médicas
16.
Urologe A ; 60(9): 1117-1124, 2021 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-34398254

RESUMEN

Clinical guidelines represent the latest standard of medical knowledge concerning diagnostics, treatment and follow up of diseases and should support doctors and patients to choose the best treatment. Depending on the prevalence of a disease there exist less or more published data. Therefore, several levels of guidelines are possible. In case of few data the expertise of the attending physicians is of greater importance (S1, S2-guidelines). In case of a huge amount of literature, especially phase III studies or metaanalyses, a S3-guideline can be written. The article describes the process of developing a guideline in Germany under the guidance of the Association of the Scientific Medical Societies in Germany (AWMF) in comparison to the process by the European Association of Urology (EAU). The aim for the future is to join resources. Another aspect of the article is to inform about different procedures how to control the implementation of the guidelines.


Asunto(s)
Médicos , Sociedades Médicas , Alemania , Humanos
17.
Med Phys ; 48(8): 4657-4710, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34402550
19.
Endocrinol Metab (Seoul) ; 36(4): 757-765, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34399446

RESUMEN

Since the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most countries, both mRNA and DNA vaccines have been administered, and their side effects have also been reported. The clinical course of COVID-19 and the effects of vaccination against COVID-19 are both influenced by patients' health status and involve a systemic physiological response. In view of the systemic function of endocrine hormones, endocrine disorders themselves and the therapeutics used to treat them can influence the outcomes of vaccination for COVID-19. However, there are very limited data to support the development of clinical guidelines for patients with specific medical backgrounds based on large clinical trials. In the current severe circumstances of the COVID-19 pandemic, position statements made by clinical specialists are essential to provide appropriate recommendations based on both medical evidence and clinical experiences. As endocrinologists, we would like to present the medical background of COVID-19 vaccination, as well as precautions to prevent the side effects of COVID-19 vaccination in patients with specific endocrine disorders, including adrenal insufficiency, diabetes mellitus, osteoporosis, autoimmune thyroid disease, hypogonadism, and pituitary disorders.


Asunto(s)
Vacunas contra la COVID-19/normas , COVID-19/prevención & control , Enfermedades del Sistema Endocrino , Endocrinólogos/normas , Sociedades Médicas/normas , Vacunación/normas , COVID-19/epidemiología , COVID-19/inmunología , Vacunas contra la COVID-19/administración & dosificación , Vacunas contra la COVID-19/efectos adversos , Enfermedades del Sistema Endocrino/epidemiología , Enfermedades del Sistema Endocrino/inmunología , Humanos , Guías de Práctica Clínica como Asunto/normas , República de Corea/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...